pLVX-TetOne-Puro-hAXL Citations (2)

Originally described in: AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.
Axelrod HD, Valkenburg KC, Amend SR, Hicks JL, Parsana P, Torga G, DeMarzo AM, Pienta KJ Mol Cancer Res. 2019 Feb;17(2):356-369. doi: 10.1158/1541-7786.MCR-18-0718. Epub 2018 Oct 5. PubMed Journal

---

Articles Citing pLVX-TetOne-Puro-hAXL

Articles
The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress. Liu Y, Feng J, Yuan K, Wu Z, Hu L, Lu Y, Li K, Guo J, Chen J, Ma C, Pang X. Elife. 2022 May 3;11:e69255. doi: 10.7554/eLife.69255. PubMed
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-kappaB Signaling. Turi M, Anilkumar Sithara A, Hofmanova L, Zihala D, Radhakrishnan D, Vdovin A, Knapkova S, Sevcikova T, Chyra Z, Jelinek T, Simicek M, Gulla A, Anderson KC, Hajek R, Hrdinka M. Int J Mol Sci. 2023 Mar 15;24(6):5623. doi: 10.3390/ijms24065623. PubMed

If you have published an article using this material, please email us at to have your article added to this page.